Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Inhibiting Cellular Senescence: A New Therapeutic Paradigm for Age-Related Osteoporosis

Open access
Khosla, Sundeep, Farr, Joshua N, Kirkland, James L · 2018 · The Journal of Clinical Endocrinology & Metabolism

Abstract

Context: With the aging of the population and projected increase in osteoporotic fractures coupled with the declining use of osteoporosis medications, there is a compelling need for new approaches to treat osteoporosis. Given that age-related osteoporosis generally coexists with multiple other comorbidities (e.g., atherosclerosis, diabetes, frailty) that share aging as the leading risk factor, there is growing interest in the “Geroscience Hypothesis,” which posits that manipulation of fundamental aging mechanisms will delay the appearance or severity of multiple chronic diseases because these diseases share aging as the underlying risk factor. In this context, one fundamental aging mechanism that has received considerable attention recently as contributing to multiple age-related morbidities is cellular senescence. This mini-review provides an overview on cellular senescence with a focus on its role in mediating age-related bone loss. Methods: This summary is based on the authors’ knowledge of the field supplemented by a PubMed search using the terms “senescence,” “aging,” and “bone.” Results: There is compelling evidence from preclinical models and supportive human data demonstrating an increase in senescent cells in the bone microenvironment with aging. These cells produce a proinflammatory secretome that leads to increased bone resorption and decreased bone formation, and approaches that either eliminate senescent cells or impair the production of their proinflammatory secretome have been shown to prevent age-related bone loss in mice. Conclusions: Targeting cellular senescence represents a novel therapeutic strategy to prevent not only bone loss but potentially multiple age-related diseases simultaneously.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2017-02694

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 42 references

Cited by

See all 142

Metadata

Authors
Khosla, S., Farr, J. N., & Kirkland, J. L.
Affiliations
Mayo Clinic (US)
Corresponding author
Khosla, Sundeep
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2018-02-07
Volume
103
Issue
4
Pages
1282-1290
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2789912326
Cited by
130
References
42
Citations by year
2026: 9 · 2025: 9 · 2024: 19 · 2023: 11 · 2022: 13 · 2021: 21 · 2020: 24 · 2019: 17 · 2018: 7
FWCI
2.27
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (R01AG048792, P01AG004875, R37AG013925)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (K01AR070241, R01AR027065)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
cellular senescence, senile osteoporosis, senolytics, senescence-associated secretome, bone loss, bone microenvironment, bone resorption, bone formation, aging, osteoporotic fractures, comorbidities
MeSH terms
Aging, Animals, Bone and Bones, Chronic Disease, Humans, Osteoporosis, Comorbidity, Bone Remodeling, Cellular Senescence, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibiting Cellular Senescence: A New Therapeutic Paradigm for Age-Related Osteoporosis. https://app.cochat.ai/papers/10.1210/jc.2017-02694
The paper
Khosla, S., Farr, J. N., & Kirkland, J. L. (2018). Inhibiting Cellular Senescence: A New Therapeutic Paradigm for Age-Related Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2017-02694

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.